The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Open accessAbstract
Induced pluripotent stem (iPS) cells can be generated from somatic cells by the introduction of Oct3/4 (also known as Pou5f1), Sox2, Klf4 and c-Myc, in mouse and in human. The efficiency of this process, however, is low. Pluripotency can be induced without c-Myc, but with even lower efficiency. A p53 (also known as TP53 in humans and Trp53 in mice) short-interfering RNA (siRNA) was recently shown to promote human iPS cell generation, but the specificity and mechanisms remain to be determined. Here we report that up to 10% of transduced mouse embryonic fibroblasts lacking p53 became iPS cells, even without the Myc retrovirus. The p53 deletion also promoted the induction of integration-free mouse iPS cells with plasmid transfection. Furthermore, in the p53-null background, iPS cells were generated from terminally differentiated T lymphocytes. The suppression of p53 also increased the efficiency of human iPS cell generation. DNA microarray analyses identified 34 p53-regulated genes that are common in mouse and human fibroblasts. Functional analyses of these genes demonstrate that the p53-p21 pathway serves as a barrier not only in tumorigenicity, but also in iPS cell generation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that OSKM induction activates the p53–p21 pathway25.”
From In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche (2021) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citationInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationInduced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438
Self-citationIn vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R. K., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,732
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Self-citationGeneration of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,056
Self-citationMaherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Plat-E: an efficient and stable system for transient packaging of retroviruses
MORITA, S., Kojima, T., & Kitamura, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301206 · Cited by 1,660
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,003
LncRNAs regulating stemness in aging
Sousa‐Franco, A., Rebelo, K., da Rocha, S. T., & de Jesus, B. B. (2018) · Aging Cell · doi:10.1111/acel.12870 · Cited by 38
Takase, O., Yoshikawa, M., Idei, M., Hirahashi, J., Fujita, T., Takato, T., Isagawa, T., Nagae, G., Suemori, H., Aburatani, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056399 · Cited by 38
Novel Perspectives on p53 Function in Neural Stem Cells and Brain Tumors
Hede, S., Nazarenko, I., Nistér, M., & Lindström, M. S. (2010) · Journal of Oncology · doi:10.1155/2011/852970 · Cited by 40
Shimamoto, A., Yokote, K., & Tahara, H. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00010 · Cited by 38
Tidball, A. M., Neely, M., Chamberlin, R., Aboud, A. A., Kumar, K. K., Han, B., Bryan, M. R., Aschner, M., Ess, K. C., & Bowman, A. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150372 · Cited by 35
Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
Taniguchi, M., Harada, M., Dashtsoodol, N., & Kojo, S. (2015) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.91.292 · Cited by 37
Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells
Yi, L., Sun, Y., & Levine, A. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2441 · Cited by 39
Crosstalk between stem cell and cell cycle machineries
Kareta, M. S., Sage, J., & Wernig, M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.10.001 · Cited by 37
Gong, L., Pan, X., Chen, H., Rao, L., Zeng, Y., Hang, H., Peng, J., Xiao, L., & Chen, J. (2016) · Scientific Reports · doi:10.1038/srep37281 · Cited by 37
Naked Mole Rat Induced Pluripotent Stem Cells and Their Contribution to Interspecific Chimera
Lee, S., Mikhalchenko, A. E., Yim, S. H., Lobanov, A. V., Park, J., Choi, K., Bronson, R. T., Lee, C.-K., Park, T. J., & Gladyshev, V. N. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.09.013 · Cited by 38
The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis
Dehnavi, S., Sadeghi, M., Penson, P. E., Banach, M., Jamialahmadi, T., & Sahebkar, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111856 · Cited by 37
Targeting cancer stem cells from a metabolic perspective
Shen, Y., Pan, S.-C., Chu, I., Lai, R.-Y., & Wei, Y. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220909309 · Cited by 37
Embryonic Stem Cells and Induced Pluripotent Stem Cells for Skeletal Regeneration
Park, S., & Im, G. (2013) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2013.0530 · Cited by 37
Şahin, İ. H., Iacobuzio–Donahue, C. A., & O'Reilly, E. M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1094057 · Cited by 39
Saito, H., Okita, K., Chang, A. E., & Ito, F. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1742 · Cited by 38
Self-citationCulturing of mouse and human cells on soft substrates promote the expression of stem cell markers
Higuchi, S., Watanabe, T. M., Kawauchi, K., Ichimura, T., & Fujita, H. (2013) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2013.11.011 · Cited by 36
Vitamin C facilitates pluripotent stem cell maintenance by promoting pluripotency gene transcription
Gao, Y., Yang, L., Chen, L., Wang, X., Wu, H., Ai, Z., Du, J., Liu, Y., Shi, X., Wu, Y., et al. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.001 · Cited by 36
Understanding the roadmaps to induced pluripotency
Liu, K., Song, Y., Yu, H., & Zhao, T. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.205 · Cited by 36
Stem Cells: The Pursuit of Genomic Stability
Wyles, S. P., Brandt, E. B., & Nelson, T. J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151120948 · Cited by 36
Mutations in Bone Marrow-Derived Stromal Stem Cells Unmask Latent Malignancy
Houghton, J., Li, H., Fan, X., Liu, Y., Liu, J. H., Rao, V. P., Poutahidis, T., Taylor, C. L., Jackson, E. A., Hewes, C., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0439 · Cited by 36
Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs
Yang, C., & Rana, T. M. (2012) · Molecular BioSystems · doi:10.1039/c2mb25088h · Cited by 36
Direct Conversion of Somatic Cells into Induced Neurons
An, N., Xu, H., Gao, W., & Yang, H. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0350-0 · Cited by 36
Terada, Y., Jo, N., Arakawa, Y., Sakakura, M., Yamada, Y., Ukai, T., Kabata, M., Mitsunaga, K., Mineharu, Y., Ohta, S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.009 · Cited by 36
Self-citationFrom clocks to dominoes: lessons on cell cycle remodelling from embryonic stem cells
Padgett, J., & Santos, S. D. M. (2020) · FEBS Letters · doi:10.1002/1873-3468.13862 · Cited by 40
Deciphering the roadmap of in vivo reprogramming toward pluripotency
Chondronasiou, D., Martínez de Villarreal, J., Melendez, E., Lynch, C. J., Pozo, N. D., Kovatcheva, M., Aguilera, M., Prats, N., Real, F. X., & Serrano, M. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.09.009 · Cited by 34
Kotini, A. G., Carcamo, S., Cruz‐Rodriguez, N., Olszewska, M., Wang, T., Demircioğlu, D., Chang, C.-J., Bernard, E., Chao, M. P., Majeti, R., et al. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0167 · Cited by 37
Sox2 Transduction Enhances Cardiovascular Repair Capacity of Blood-Derived Mesoangioblasts
Koyanagi, M., Iwasaki, M., Rupp, S., Tedesco, F. S., Yoon, C., Boeckel, J., Trauth, J., Schütz, C., Ohtani, K., Goetz, R., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.206045 · Cited by 36
G1 checkpoint is compromised in mouse ESCs due to functional uncoupling of p53-p21Waf1 signaling
Suvorova, I. I., Grigorash, B. B., Chuykin, I. A., Pospelova, T. V., & Pospelov, V. A. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1120927 · Cited by 36
How far are induced pluripotent stem cells from the clinic?
Li, M.-R., Chen, M.-X., Han, W.-D., & Fu, X.-B. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.03.001 · Cited by 38
Li, Y., & Geng, Y. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.09.005 · Cited by 35
Hasegawa, K., Zhang, P., Wei, Z., Pomeroy, J. E., Lu, W., & Pera, M. F. (2010) · Stem Cells · doi:10.1002/stem.466 · Cited by 35
Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells
Knappe, N., Novak, D., Weina, K., Bernhardt, M., Reith, M., Larribère, L., Hölzel, M., Tüting, T., Gebhardt, C., Umansky, V., et al. (2016) · Stem Cells · doi:10.1002/stem.2284 · Cited by 36
Srf destabilizes cellular identity by suppressing cell-type-specific gene expression programs
Ikeda, T., Hikichi, T., Miura, H., Shibata, H., Mitsunaga, K., Yamada, Y., Woltjen, K., Miyamoto, K., Hiratani, I., Yamada, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03748-1 · Cited by 37
Self-citationEpisomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications
Wang, A. Y. L., & Loh, C. Y. Y. (2019) · Cell Transplantation · doi:10.1177/0963689719886534 · Cited by 35
Inagaki, T., Sato, Y., Ito, J., Takaki, M., Okuno, Y., Yaguchi, M., Masud, H. M. A. A., Watanabe, T., Sato, K., Iwami, S., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.575255 · Cited by 35
Alternative Sources of Pluripotent Stem Cells: Ethical and Scientific Issues Revisited
Condic, M. L., & Rao, M. S. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0482 · Cited by 35
Induced pluripotent stem cells: advances to applications
Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Ikeda, Y., Perez-Terzic, C., & Terzic, A. (2009) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s4954 · Cited by 36
Jabbour, A. M., Daunt, C. P., Green, B. D., Vogel, S., Gordon, L., Lee, R. S., Silke, N., Pearson, R. B., Vandenberg, C. J., Kelly, P. N., et al. (2009) · Blood · doi:10.1182/blood-2009-07-230730 · Cited by 34
The winding road to pluripotency (Nobel Lecture).
Yamanaka, S. (2013) · Angewandte Chemie · doi:10.1002/anie.201306721 · Cited by 28
Self-citationmiR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1–Sox2 axis
Zhang, Y., Pan, Y., Xie, C., & Zhang, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0778-4 · Cited by 34
Remodeling of mitochondrial morphology and function: an emerging hallmark of cellular reprogramming
Rastogi, A., Joshi, P. K., Contreras, E., & Gama, V. (2019) · Cell Stress · doi:10.15698/cst2019.06.189 · Cited by 36
Induced pluripotent stem cells: origins, applications, and future perspectives
Zhao, J. Y., Jiang, W., Sun, C., Hou, C., Yang, X., & Gao, J. (2013) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1300215 · Cited by 34
Gadd45a and Gadd45g regulate neural development and exit from pluripotency in Xenopus
Kaufmann, L. T., & Niehrs, C. (2011) · Mechanisms of Development · doi:10.1016/j.mod.2011.08.002 · Cited by 35
Induction of Retinal Progenitors and Neurons from Mammalian Müller Glia under Defined Conditions
Zhao, J. J., Ouyang, H. W., Luo, J., Patel, S. H., Xue, Y., Quach, J., Sfeir, N., Zhang, M., Fu, X., Ding, S., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532671 · Cited by 33
Liu, X.-J., Huang, Q., Li, F., & Li, C.-Y. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4730-2 · Cited by 29
Metabolome and metaboproteome remodeling in nuclear reprogramming
Folmes, C. D. L., Arrell, D. K., Zlatković, J., Martinez‐Fernandez, A., Pérez-Terzic, C. M., Nelson, T. J., & Terzic, A. (2013) · Cell Cycle · doi:10.4161/cc.25509 · Cited by 35
A critical role for AID in the initiation of reprogramming to induced pluripotent stem cells
Bhutani, N., Decker, M. N., Brady Jennifer, J., Bussat, R. T., Burns, D. M., Corbel, S. Y., & Blau, H. M. (2012) · The FASEB Journal · doi:10.1096/fj.12-222125 · Cited by 37
Cho, W., Jin, X., Pang, J., Wang, Y., Mivechi, N. F., & Moskophidis, D. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00391-18 · Cited by 33
p53 balances between tissue hierarchy and anarchy
Koifman, G., Aloni-Grinstein, R., & Rotter, V. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz022 · Cited by 33
Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues
Alle, Q., Le Borgne, E., Milhavet, O., & Lemaitre, J.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083990 · Cited by 35
Liver Regenerative Medicine: Advances and Challenges
Chistiakov, D. A. (2012) · Cells Tissues Organs · doi:10.1159/000335697 · Cited by 33
Musculoskeletal regeneration and its implications for the treatment of tendinopathy
Sereysky, J. B., Flatow, E. L., & Andarawis‐Puri, N. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12031 · Cited by 34
10th anniversary of iPS cells: the challenges that lie ahead
Aoi, T. (2016) · The Journal of Biochemistry · doi:10.1093/jb/mvw044 · Cited by 33
Self-citationScaffidi, P., & Misteli, T. (2010) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2010.75.007 · Cited by 33
Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseases
Shi, L., Cui, Y., Luan, J. Y., Zhou, X., & Han, J. (2016) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2016.01062 · Cited by 33
The role of NF-κB and miRNA in oral cancer and cancer stem cells with or without HPV16 infection
Bano, N., Yadav, M. C., Mohania, D., & Das, B. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205518 · Cited by 32
RetractedMicroRNAs in Cancer Translational Research
Cho, W. C. S. (2011) · Springer eBooks · doi:10.1007/978-94-007-0298-1 · Cited by 32
Peng, Q., Lao, X., Chen, Z., Lai, H., Deng, Y., Wang, J., Mo, C., Sui, J., Wu, J., Zhai, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082773 · Cited by 32
ROCK1 functions as a critical regulator of stress erythropoiesis and survival by regulating p53
Vemula, S., Shi, J., Mali, R. S., Ma, P., Liu, Y., Hanneman, P., Koehler, K. R., Hashino, E., Wei, L., & Kapur, R. (2012) · Blood · doi:10.1182/blood-2011-10-384172 · Cited by 33
The relevance of protein-protein interactions for p53 function: the CPE contribution
Fernández-Fernández, M. R., & Sot, B. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq074 · Cited by 33
Embryonic stem cell miRNAs and their roles in development and disease
Vidigal, J. A., & Ventura, A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.009 · Cited by 32
Chen, X. X., Zhai, Y., Yu, D., Cui, J., Hu, J., & Li, W. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25270 · Cited by 33
Gadd45a is a heterochromatin relaxer that enhances iPS cell generation
Chen, K., Long, Q., Wang, T., Zhao, D., Zhou, Y., Qi, J., Wu, Y., Li, S., Chen, C., Zeng, X., et al. (2016) · EMBO Reports · doi:10.15252/embr.201642402 · Cited by 37
Liu, S., Fu, R., Wu, D., Hsu, C.-Y., Chang, C., Lee, W., Lee, Y.-D., Liu, C. H., Chien, Y.-J., Lin, S., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0182 · Cited by 31
Apoptosis: Reprogramming and the Fate of Mature Cells
Cheung, H., Liu, X., & Rennert, O. M. (2012) · ISRN Cell Biology · doi:10.5402/2012/685852 · Cited by 32
Ishii, R., Kami, D., Toyoda, M., Makino, H., Gojo, S., Ishii, T., & Umezawa, A. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-10-0869 · Cited by 31
Myc orchestrates a regulatory network required for the establishment and maintenance of pluripotency
Smith, K. N., Lim, J.-M., Wells, L., & Dalton, S. (2011) · Cell Cycle · doi:10.4161/cc.10.4.14792 · Cited by 32
Puzio‐Kuter, A. M., & Levine, A. J. (2009) · Nature Biotechnology · doi:10.1038/nbt1009-914 · Cited by 31
The ups and downs of p53 regulation in hematopoietic stem cells
Abbas, H. A., Pant, V., & Lozano, G. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17721 · Cited by 33
Modeling blood diseases with human induced pluripotent stem cells
Georgomanoli, M., & Papapetrou, E. P. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039321 · Cited by 35
P53 Regulates Rapid Apoptosis in Human Pluripotent Stem Cells
Setoguchi, K., TeSlaa, T. A., Koehler, C. M., & Teitell, M. A. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.07.019 · Cited by 31
Chu, Z., Niu, B., Zhu, H., He, X., Bai, C., Li, G., & Hua, J. (2014) · Cell Proliferation · doi:10.1111/cpr.12150 · Cited by 31
Methods for iPS cell generation for basic research and clinical applications
Mochiduki, Y., & Okita, K. (2012) · Biotechnology Journal · doi:10.1002/biot.201100356 · Cited by 31
Self-citationHeterozygous loss of TSC2 alters p53 signaling and human stem cell reprogramming
Armstrong, L. C., Westlake, G. M., Snow, J. P., Cawthon, B., Armour, E. A., Bowman, A. B., & Ess, K. C. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx345 · Cited by 31
Hu, W., He, Y., Xiong, Y., Lu, H., Chen, H., Hou, L., Qiu, Z., Yu, F., & Zhang, S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9084-z · Cited by 30
Chlon, T. M., Hoskins, E. E., Mayhew, C. N., Wikenheiser‐Brokamp, K. A., Davies, S. M., Mehta, P. A., Myers, K. C., Wells, J. M., & Wells, S. I. (2014) · Journal of Virology · doi:10.1128/jvi.01533-14 · Cited by 30
SUMOylation of KLF4 acts as a switch in transcriptional programs that control VSMC proliferation
Nie, C.-J., Li, Y. H., Zhang, X., Wang, Z.-P., Jiang, W., Zhang, Y., Yin, W., Zhang, Y., Shi, H., Liu, Y., et al. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.03.001 · Cited by 31
p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer
Sui, X. Y., Cai, J., Li, H., He, C., Zhou, C., Dong, Y., Chen, L., Zhang, B., Wang, Y., Zhang, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0541-x · Cited by 30
MicroRNA Roles in Cell Reprogramming Mechanisms
Pascale, E., Caiazza, C., Paladino, M., Parisi, S., Passaro, F., & Caiazzo, M. (2022) · Cells · doi:10.3390/cells11060940 · Cited by 30
Amphiregulin mediates non-cell-autonomous effect of senescence on reprogramming
von Joest, M., Chen, C., Douché, T., Chantrel, J., Chiche, A., Gianetto, Q. G., Matondo, M., & Li, H. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111074 · Cited by 31
The role of truncated p53 isoforms in the DNA damage response
Reinhardt, L. S., Groen, K., Newton, C., & Avery‐Kiejda, K. A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188882 · Cited by 31
Context‐Dependent Enhancement of Induced Pluripotent Stem Cell Reprogramming by Silencing Puma
Lake, B. B., Fink, J., Klemetsaune, L., Fu, X., Jeffers, J. R., Zambetti, G. P., & Xu, Y. (2012) · Stem Cells · doi:10.1002/stem.1054 · Cited by 30
Vicente‐Dueñas, C., Hauer, J., Ruiz-Roca, L., Ingenhag, D., Rodríguez-Meira, A., Auer, F., Borkhardt, A., & Sánchez-Garcı́a, I. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.02.001 · Cited by 31
Itahana, Y., Zhang, J., Göke, J., Vardy, L. A., Han, R., Iwamoto, K., Cukuroglu, E., Robson, P., Pouladi, M. A., Colman, A., et al. (2016) · Scientific Reports · doi:10.1038/srep28112 · Cited by 30
Firat, E., & Niedermann, G. (2016) · Oncotarget · doi:10.18632/oncotarget.10702 · Cited by 30
p53 and its mutants on the slippery road from stemness to carcinogenesis
Molchadsky, A., & Rotter, V. (2017) · Carcinogenesis · doi:10.1093/carcin/bgw092 · Cited by 30
Prospects for the involvement of cancer stem cells in the pathogenesis of osteosarcoma
Izadpanah, S., Shabani, P., Aghebati‐Maleki, A., Baghbanzadeh, A., Fotouhi, A., Bisadi, A., Maleki, L. A., & Baradaran, B. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29344 · Cited by 31
Induced Pluripotent Stem Cells
Fakoya, A. O. J., Omole, A. E., Satyadev, N., & Haider, K. H. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_40-1 · Cited by 29
Twists in views on RB functions in cellular signaling, metabolism and stem cells
Takahashi, C., Sasaki, N., & Kitajima, S. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02284.x · Cited by 29
The evolving cancer stem cell paradigm: Implications in veterinary oncology
Pang, L. Y., & Argyle, D. J. (2015) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.12.029 · Cited by 29
Reprogramming cell fate to pluripotency: the decision-making signalling pathways
Sanges, D., & Cosma, M. P. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103190ds · Cited by 29
Liu, W., Long, Q., Chen, K., Li, S., Xiang, G., Chen, S., Li, Y., Li, Y., Yang, L., Dong, D., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.148 · Cited by 29
Razak, S. R. A., Ueno, K., Takayama, N., Nariai, N., Nagasaki, M., Saito, R., Koso, H., Lai, C., Murakami, M., Tsuji, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073532 · Cited by 29
Conversion of Fibroblasts to Neural Cells by p53 Depletion
Zhou, D., Zhang, Z., He, L.-M., Du, J., Zhang, F., Sun, C.-K., Zhou, Y., Wang, X., Lin, G., Song, K.-M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.040 · Cited by 29
Marzi, I., Cipolleschi, M. G., D’Amico, M., Stivarou, T., Rovida, E., Vinci, M. C., Pandolfi, S., Sbarba, P. D., Stecca, B. A., & Olivotto, M. (2013) · Cell Cycle · doi:10.4161/cc.23200 · Cited by 29
Declined Expression of Histone Deacetylase 6 Contributes to Periodontal Ligament Stem Cell Aging
Li, Q., Ma, Y., Zhu, Y., Zhang, T., & Zhou, Y. (2016) · Journal of Periodontology · doi:10.1902/jop.2016.160338 · Cited by 29
Momčilović, O., Navara, C. S., & Schatten, G. P. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-19065-0_18 · Cited by 30
Genetic instability of modified stem cells - a first step towards malignant transformation?
Steinemann, D., Göhring, G., & Schlegelberger, B. (2013) · Europe PMC (PubMed Central) · Cited by 29
Shaykhiev, R., Wang, R., Zwick, R. K., Hackett, N. R., Leung, R., Moore, M. A. S., Sima, C. S., Chao, I. W., Downey, R. J., Strulovici‐Barel, Y., et al. (2013) · Stem Cells · doi:10.1002/stem.1459 · Cited by 29
Failsafe program escape and EMT: A deleterious partnership
Ansieau, S., Courtois-Cox, S., Morel, A., & Puisieux, A. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.014 · Cited by 31
Metadata
- Authors
- Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S.
- Affiliations
- Kyoto University (JP)
- RIKEN (JP)
- Gladstone Institutes (US)
- Corresponding author
- Yamanaka, Shinya
- Venue
- Nature
- Published
- 2009-08
- Volume
- 460
- Issue
- 7259
- Pages
- 1132-1135
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2917235
- OpenAlex
- W2081620485
- Cited by
- 1,301
- References
- 23
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 25 · 2023: 29 · 2022: 44 · 2021: 51 · 2020: 41 · 2019: 56 · 2018: 63 · 2017: 59 · 2016: 78 · 2015: 88 · 2014: 116 · 2013: 117 · 2012: 168
- FWCI
- 67.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (U01HL100406)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- induced pluripotent stem cells, p53, p21, p53/p21 pathway, reprogramming efficiency, mouse embryonic fibroblasts, T cells, plasmid transfection, p53 target genes, tumorigenicity, Oct4, SOX2, KLF4, c-Myc
- MeSH terms
- Kruppel-Like Factor 4, Adult, Animals, Cell Differentiation, Embryo, Mammalian, Female, Fibroblasts, Humans, Male, Plasmids, T-Lymphocytes, Transfection, Tumor Suppressor Protein p53, Genes, myc, Oligonucleotide Array Sequence Analysis, Gene Silencing, Gene Expression Profiling, Pluripotent Stem Cells, Cyclin-Dependent Kinase Inhibitor p21, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
